Depixus

Courbevoie, France

Depixus are pioneering the development of MAGNA, a novel genetic analysis technology for decoding the dynamic genome.

Dec 2021

Series A

Top Investors

BpifranceCasdin CapitalEISMEAArix BioscienceLansdowne Partners

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Depixus's investors?

Depixus's investors include Bpifrance, Casdin Capital, EISMEA, Arix Bioscience, Lansdowne Partners.

Where is Depixus headquartered?

Depixus is headquartered in Courbevoie, France.

What does Depixus do?

Depixus are pioneering the development of MAGNA, a novel genetic analysis technology for decoding the dynamic genome.

What stage is Depixus at?

Depixus is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 15, 2021.

MLA

"Depixus — Funding & Investors." VCBacked, December 15, 2021, https://www.vcbacked.co/company/depixus. Accessed July 1, 2026.

APA

VCBacked. (2021). Depixus — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/depixus

Wikipedia (cite web)

{{cite web |title=Depixus — Funding & Investors |url=https://www.vcbacked.co/company/depixus |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 15, 2021.